Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Total Liabilities (Quarterly) : 110.72M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 110.72M |
| March 31, 2026 | 118.11M |
| December 31, 2025 | 413.48M |
| September 30, 2025 | 125.86M |
| June 30, 2025 | 116.18M |
| March 31, 2025 | 112.34M |
| December 31, 2024 | 105.71M |
| September 30, 2024 | 93.56M |
| June 30, 2024 | 85.97M |
| March 31, 2024 | 82.04M |
| December 31, 2023 | 74.92M |
| September 30, 2023 | 68.94M |
| June 30, 2023 | 64.09M |
| March 31, 2023 | 65.10M |
| December 31, 2022 | 136.37M |
| September 30, 2022 | 126.20M |
| June 30, 2022 | 119.19M |
| March 31, 2022 | 151.18M |
| December 31, 2021 | 164.15M |
| September 30, 2021 | 329.95M |
| June 30, 2021 | 378.61M |
| March 31, 2021 | 385.66M |
| December 31, 2020 | 395.85M |
| September 30, 2020 | 239.64M |
| June 30, 2020 | 96.22M |
| Date | Value |
|---|---|
| March 31, 2020 | 44.18M |
| December 31, 2019 | 55.70M |
| September 30, 2019 | 64.68M |
| June 30, 2019 | 67.71M |
| March 31, 2019 | 82.97M |
| December 31, 2018 | |
| September 30, 2018 | 93.47M |
| June 30, 2018 | 112.27M |
| March 31, 2018 | 112.80M |
| December 31, 2017 | 96.20M |
| September 30, 2017 | 92.58M |
| June 30, 2017 | 82.63M |
| March 31, 2017 | 84.95M |
| December 31, 2016 | 79.40M |
| September 30, 2016 | 53.96M |
| June 30, 2016 | 70.58M |
| March 31, 2016 | 68.42M |
| December 31, 2015 | 75.47M |
| September 30, 2015 | 109.00M |
| June 30, 2015 | 140.42M |
| March 31, 2015 | 120.11M |
| December 31, 2014 | 93.47M |
| September 30, 2014 | 60.61M |
| June 30, 2014 | 42.45M |
| March 31, 2014 | 43.57M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 76.02M |
| Shareholders Equity (Quarterly) | -34.70M |
| Debt to Equity Ratio | -1.818 |
| Current Ratio | 0.0351 |
| Net Debt Paydown Yield | 0.38% |